37 CFR 104.2 - Address for mail and service; telephone number

Cite as37 CFR 104.2
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
86 practice notes
  • Part II
    • United States
    • Federal Register August 14, 2008
    • 14 Agosto 2008
    ...the necessity of serving the USPTO Director and complying with service requirements of Rule 4 of the Federal Rules of Civil Procedure and 37 CFR 104.2. Section 11.57(b), unlike former Sec. 10.156(b), provides that except for a request for reconsideration in Sec. 11.56(c), ``an order for dis......
  • Practice and procedure: Representation of others before United States Patent and Trademark Office; changes,
    • United States
    • Federal Register February 28, 2007
    • 28 Febrero 2007
    ...practitioner's attention to the necessity for complying with service requirements of Rule 4 of the Federal Rules of Civil Procedure and 37 CFR 104.2. Section 11.57(b), as revised, provides that except as provided for in Sec. 11.56(c), an order for discipline in a final decision will not be ......
  • Part III
    • United States
    • Federal Register February 28, 2007
    • 28 Febrero 2007
    ...practitioner's attention to the necessity for complying with service requirements of Rule 4 of the Federal Rules of Civil Procedure and 37 CFR 104.2. Section 11.57(b), as revised, provides that except as provided for in Sec. 11.56(c), an order for discipline in a final decision will not be ......
  • Miscellaneous Changes to Trademark Trial and Appeal Board Rules of Practice
    • United States
    • Federal Register October 07, 2016
    • 7 Octubre 2016
    ...via ESTTA. In addition, requests to extend the time for filing an appeal, or commencing a civil action, are to be filed as provided in 37 CFR 104.2 and addressed to the attention of the Office of the Solicitor, and a copy should be filed with the Board via Public Participation The Board beg......
  • Request a trial to view additional results
82 cases
  • Apple, Inc. v. X One, Inc., Patent Interference 106
    • United States
    • United States Patent and Trademark Office. United States Patent and Trademark Office, Patent Trial and Appeal Board
    • 4 Septiembre 2015
    ...a party seeking judicial review timely serve notice on the Director of the United States Patent and Trademark Office (37 C.F.R. §§ 90.1 and 104.2); and FURTHER ORDERED that attention is directed to Biogen Idec MA, Inc., v. Japanese Foundation for Cancer Research, 785 F.3d 648, 654-57 (Fed. ......
  • Thomas v. Pippin, Patent Interference 105
    • United States
    • United States Patent and Trademark Office. United States Patent and Trademark Office, Patent Trial and Appeal Board
    • 26 Enero 2015
    ...timely serve notice on the Director of the United States Patent and Trademark Office, Patent Trial and Appeal Board (37 C.F.R. §§ 90.1 and 104.2); and FURTHER ORDERED that attention is directed to Biogen Idec MA, Inc., v. Japanese Foundation for Cancer Research, 2014 WL 2167677 (D. Mass. 20......
  • EcoServices LLC v. Lufthansa Technik Ag, Patent Interference 106
    • United States
    • United States Patent and Trademark Office. United States Patent and Trademark Office, Patent Trial and Appeal Board
    • 20 Diciembre 2018
    ...a party seeking judicial review timely serve notice on the Director of the United States Patent and Trademark Office; 37 C.F.R. §§ 90.1 and 104.2. See also 37 C.F.R. § 41.8(b). Attention is directed to Biogen Idec MA, Inc., v. Japanese Foundation for Cancer Research, 785 F.3d 648, 654-57 (F......
  • Bergendahl v. Sasai, Patent Interference 106
    • United States
    • United States Patent and Trademark Office. United States Patent and Trademark Office, Patent Trial and Appeal Board
    • 29 Junio 2016
    ...a party seeking judicial review timely serve notice on the Director of the United States Patent and Trademark Office. 37 C.F.R. §§ 90.1 and 104.2. See also Bd. R. 8(b). Attention is directed to Biogen Idee MA, Inc., v. Japanese Foundation for Cancer Research, 785 F.3d 648, 654-57 (Fed. Cir.......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT